You are here

Tezspire

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

Pharma Voice

Thu, 03/27/25 - 11:06 am

chronic rhinosinusitis with nasal polyps

Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP

Clinical Trials Arena

Mon, 03/3/25 - 10:19 am

clinical trials

chronic rhinosinusitis with nasal polyps

AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial

Clinical Trials Arena

Fri, 11/8/24 - 11:34 am

clinical trials

chronic rhinosinusitis with nasal polyps

Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD

Fierce Pharma

Mon, 05/20/24 - 11:25 am

Amgen Highlights New COPD, Asthma and Vasculitis Research at ATS 2024

BioSpace

Wed, 05/1/24 - 09:31 am

AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE

Fierce Pharma

Wed, 03/29/23 - 09:58 am

AstraZeneca wins two recommendations, one priority review

Morningstar

Mon, 07/25/22 - 10:54 am

AstraZeneca, Amgen tap Brand Institute in new naming twist for their freshly approved Tezspire

Fierce Pharma

Thu, 01/6/22 - 11:52 am

Broad Institute

AstraZeneca and Amgen’s asthma biologic approved in the US

Biopharma Reporter

Mon, 12/20/21 - 11:08 am

Go or no go? Roche’s fresh start for a new year

EP Vantage

Mon, 12/20/21 - 10:59 am